Fundraising Fox

Proscia

Philadelphia, US · Founded 2014 · Delaware corporation · 125 employees on LinkedIn · 15 known investors

Proscia provides a digital pathology software platform that converts glass microscope slides into high-resolution digital images for viewing, management, and analysis by pathologists and research teams. The platform enables clinical laboratories and life sciences organizations to improve workflow efficiency, support remote collaboration, and integrate artificial intelligence tools for quantitative tissue analysis and biomarker detection.

AI & Machine LearningBiotechHealthtechMedical Devices

Founders & leadership

Proscia was founded in 2014 by David West, Jr. and David West.

DW
David West, Jr.Co-founder
DWDavid West
David WestinCo-Founder, CEODavid West is an executive officer and director at Proscia, which develops a digital pathology software platform that digitizes glass microscope slides and applies AI tools for tissue analysis and diagnostics used by clinical labs and life sciences organizations.
DW
David West, Sr.Executive

Board

ANAlex Niehenke
Alex Niehenkein𝕏Board MemberPartner at Scale Venture Partners
TLTom Loftus
Tom LoftusBoard directorManaging Partner at Razor's Edge Ventures
RE
Robert EpsteinBoard director

Investors · 15

Alpha Intelligence CapitalSan Francisco
Emerald Development ManagersNew York
Flybridge Capital PartnersNew York · $250K – $10M
FusionPalo Alto · $500K – $1M
Green Park & Golf VenturesDallas · $500K – $2M
Hitachi VenturesMunich
Maryland TEDCOUpper Marlboro · $500K – $1.5M
Razor's Edge VenturesReston · $2M – $4M
Robin Hood VenturesPhiladelphia · $250K – $1Mvia Pitou Devgon · inferred
TEDCOColumbia
Insight Partnersreported · 2 sourcesNew York · $120M – $350M
Interwoven Venturesreported
Scale Venture PartnersreportedSan Francisco · $5M – $25Mvia Alex Niehenke · board
SoGal VenturesreportedNew York · $50K – $500K
Triangle Peak PartnersreportedPalo Alto

Funding

SEC filings, press & company announcements

$112.8M disclosed across 7 of 9 rounds · 2014–2025

▶$35MraisedMar 2025 · 21 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alex NiehenkeDirector
  • Tom LoftusDirector
  • Robert EpsteinDirector
  • David West, Sr.Executive Officer, Director
  • David West, Jr.Executive Officer, Director
Offering amount
$35M
Amount sold
$35M
First sale
Mar 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9MraisedJan 2024 · 9 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jacob DoftDirector
  • David West, Sr.Executive Officer, Director
  • Tom LoftusDirector
  • David West, Jr.Executive Officer, Director
  • Stavish ColemanDirector
  • Neil L. CohenDirector
  • Alex NiehenkeDirector
Offering amount
$15M
Amount sold
$9M
First sale
Dec 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$36.6MraisedJun 2022 · 17 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jacob DoftDirector
  • Neil L. CohenDirector
  • Alexander NiehenkeDirector
  • David West, Jr.Executive Officer, Director
  • Tom LoftusDirector
  • Coleman StavishDirector
  • David West, Sr.Executive Officer, Director
Offering amount
$50M
Amount sold
$36.6M
First sale
May 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$23MraisedDec 2020 · 18 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles M. HazardDirector
  • David West, Jr.Executive Officer, Director
  • David West, Sr.Director
  • Neil L. CohenDirector
  • Alexander NiehenkeDirector
  • Coleman StavishDirector
  • Tom LoftusDirector
Offering amount
$23M
Amount sold
$23M
First sale
Nov 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.3MraisedOct 2018 · 10 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Neil L. CohenDirector
  • David West, Sr.Director
  • David West, Jr.Executive Officer, Director
Offering amount
$10M
Amount sold
$8.3M
First sale
Jul 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$927.2KraisedMay 2017 · 8 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • David West, Sr.Director
  • David West, Jr.Executive Officer, Director
  • Neil L. CohenDirector
Offering amount
$927.2K
Amount sold
$927.2K
Proceeds to insiders
$52K
First sale
Apr 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MofferedMay 2016 · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • David West, Sr.Director
  • David West, Jr.Executive Officer, Director
Offering amount
$1M
Proceeds to insiders
$52K
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$400raisedNov 2014 · 10 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • David WestExecutive Officer, Director
  • David WestDirector
Offering amount
$400
Amount sold
$400
First sale
Oct 2014
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Labcorp44 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.

Companies competing with Proscia for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

On track to diagnose 32,000 patients daily, Proscia is shaping the future of precision medicine | Insight Partnersinsightpartners.com · Feb 2026Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision Medicine - Prosciaproscia.com · Mar 2025Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision Medicineglobenewswire.com · Mar 2025Proscia Raises $50M in Fundingfinsmes.com · Mar 2025Philadelphia Medical Technology Company, Proscia, Raises $37M Series C Round | BioBuzzbiobuzz.io · Dec 2024Proscia's $46M Series C propels AI-driven pathology into the mainstream | VentureBeatventurebeat.com · Mar 2024

Frequently asked questions

What does Proscia do?
Proscia provides a digital pathology software platform that converts glass microscope slides into high-resolution digital images for viewing, management, and analysis by pathologists and research teams. The platform enables clinical laboratories and life sciences organizations to improve workflow efficiency, support remote collaboration, and integrate artificial intelligence tools for quantitative tissue analysis and biomarker detection.
Who founded Proscia?
Proscia was founded by David West, Jr., David West in 2014.
Who are Proscia's investors?
Proscia's investors include Alpha Intelligence Capital, Emerald Development Managers, Flybridge Capital Partners, Fusion, Green Park & Golf Ventures, Hitachi Ventures, Maryland TEDCO, Razor's Edge Ventures and 7 more.
How much funding has Proscia raised?
Proscia has disclosed $112.8M raised across 7 of its 9 known rounds.
Where is Proscia headquartered?
Proscia is headquartered in Philadelphia, US.